StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SRSN.JK$65.00+0.00%
Fair $65.00+0.0%

SRSN.JK

PT Indo Acidatama Tbk

Basic Materials / ChemicalsJakarta

$65.00

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $65.00Fund rank 28/100 · Data gapFallback financials|
SA 58/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 20%

FCF escenarios

weak_data · normalized FCF $16.8B · quality 48.3/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

58/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · SRSN.JKLocal privado en este navegador · PT Indo Acidatama Tbk
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$391.3B

P/E

4.1x

↓

EV/EBITDA

3.9x

↓

ROE

9.6%

↑

Gross Margin

24.8%

↑

Debt/Equity

0.14

↓
52-Week Range$65
$50$83

TradingView lightweight chart

SRSN.JK price, volumen y niveles de valoración

Último $65.00Periodo -82.6%
Fair value: $65.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+8.7%

FCF CAGR

+139.1%

FCF margin

17.6%

FCF / Net income

2.85x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.26T · net income $77.35B · FCF $220.82B

2022-FY → 2025-FY

Gross margin

24.8%+5.9% pts

Operating margin

9.6%+4.5% pts

Net margin

6.2%+2.7% pts

FCF margin

17.6%+15.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1256.36B$1256.36B$1153.79B$1026.71B$977.71B
Net Income$77.35B$77.35B$22.50B$58.02B$33.64B
EBITDA$125.70B$125.70B$49.61B$92.92B$62.49B
EPS——3.749.645.59
Gross Margin24.8%24.8%16.6%23.2%19.0%
Operating Margin9.6%9.6%3.7%8.6%5.0%
Net Margin6.2%6.2%2.0%5.7%3.4%
Balance Sheet
Debt/Equity0.140.140.430.220.25
Current Ratio4.084.08———
Cash Flow
Free Cash Flow$220.82B$220.82B$-159.44B$16.77B$16.15B
Returns
ROE9.6%9.6%3.0%8.2%5.1%
Valuation
P/E4.054.0513.376.859.30
EV/EBITDA3.943.9412.325.787.45
P/B0.480.480.410.560.48
Growth & Yield
Revenue Growth8.9%8.9%12.4%5.0%—
EPS Growth——-61.2%72.5%—
Dividend Yield1.7%1.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +29.1%

Total return

+29.1%

Start / end P/E

n/dx → n/dx

EPS bridge

3.74 → n/d

Residual

+27.5%

EPS growthn/d
Multiple reratingn/d
Dividend+1.7%
Residual / FX / buybacks / cross-term+27.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.